{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:45:55Z","timestamp":1787021155471,"version":"build-2736575974"},"reference-count":57,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"11","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2017,4,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To provide new information on adverse health outcomes (AHOs) in testicular cancer survivors (TCSs) after four cycles of etoposide and cisplatin (EPX4) or three or four cycles of bleomycin, etoposide, cisplatin (BEPX3\/BEPX4).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Nine hundred fifty-two TCSs &gt; 1 year postchemotherapy underwent physical examination and completed a questionnaire. Multinomial logistic regression estimated AHOs odds ratios (ORs) in relation to age, cumulative cisplatin and\/or bleomycin dose, time since chemotherapy, sociodemographic factors, and health behaviors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median age at evaluation was 37 years; median time since chemotherapy was 4.3 years. Chemotherapy consisted largely of BEPX3 (38.2%), EPX4 (30.9%), and BEPX4 (17.9%). None, one to two, three to four, or five or more AHOs were reported by 20.4%, 42.0%, 25.1%, and 12.5% of TCSs, respectively. Median number after EPX4 or BEPX3 was two (range, zero to nine and zero to 11, respectively; P &gt; .05) and two (range, zero to 10) after BEPX4. When comparing individual AHOs for EPX4 versus BEPX3, Raynaud phenomenon (11.6% v 21.4%; P &lt; .01), peripheral neuropathy (29.2% v 21.4%; P = .02), and obesity (25.5% v 33.0%; P = .04) differed. Larger cumulative bleomycin doses (OR, 1.44 per 90,000 IU) were significantly associated with five or more AHOs. Increasing age was a significant risk factor for one to two, three to four, or five or more AHOs versus zero AHOs (OR, 1.22, 1.50, and 1.87 per 5 years, respectively; P &lt; .01); vigorous physical activity was protective (OR, 0.62, 0.51, and 0.41, respectively; P &lt; .05). Significant risk factors for three to four and five or more AHOs included current (OR, 3.05 and 3.73) or former (OR, 1.61 and 1.76) smoking ( P &lt; .05). Self-reported health was excellent\/very good in 59.9% of TCSs but decreased as AHOs increased ( P &lt; .001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Numbers of AHOs after EPX4 or BEPX3 appear similar, with median follow-up of 4.3 years. A healthy lifestyle was associated with reduced number of AHOs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.2016.70.3108","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T15:58:00Z","timestamp":1488211080000},"page":"1211-1222","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":93,"title":["Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy"],"prefix":"10.1200","volume":"35","author":[{"given":"Chunkit","family":"Fung","sequence":"first","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard D.","family":"Sesso","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalynn M.","family":"Williams","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Kerns","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Monahan","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abu Zaid","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren R.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Vaughn","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clair J.","family":"Beard","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian K.","family":"Kollmannsberger","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Cook","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Althouse","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Ardeshir-Rouhani-Fard","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E.","family":"Lipshultz","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H.","family":"Einhorn","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie D.","family":"Fossa","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois B.","family":"Travis","sequence":"additional","affiliation":[{"name":"Chunkit Fung, Annalynn M. Williams, and Sarah L. Kerns, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Howard D. Sesso, Brigham and Women\u2019s Hospital; Clair J. Beard, Dana-Farber Cancer Institute, Boston, MA; Patrick Monahan, Mohammad Abu Zaid, Ryan Cook, Sandra Althouse, Shirin Ardeshir-Rouhani-Fard, Lawrence H. Einhorn, and Lois B. Travis, Indiana University Melvin and Bren Simon Cancer Center,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Platinum Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70246-2"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-87-3-293"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.07.044"},{"key":"B4","unstructured":"National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology. Testicular Cancer (Version 2.2016), https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/testicular.pdf"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt304"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.594"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.0896"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1407550"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.2476"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.9362"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.173"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.11.2923"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.5296"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-010-0133-y"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21349"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs473"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq216"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.8822"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.24.2705"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-005-5370-6"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/00003446-198205000-00006"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(78)90058-9"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199601000-00014"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.19.1450"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.7.524"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902043400504"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.14.1165"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.3.182"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.4.465"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12754"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.4431"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-014-1361-y"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0b013e31821ece12"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.226"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp413"},{"key":"B39","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/cncr.24981","volume":"116","author":"Glendenning JL","year":"2010","journal-title":"Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9907-6"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/BF02698037"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.12788\/jcso.0033"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.12.022"},{"key":"B44","doi-asserted-by":"crossref","unstructured":"Gamazon ER, Wheeler HE, Frisina RD, et al: Variation in protein-coding sequence and the genetic basis of cisplatin-induced toxicities among testicular cancer survivors (TCS) in the Platinum Study. J Clin Oncol 34, 2016 (suppl; abstr 1537)","DOI":"10.1200\/JCO.2016.34.15_suppl.1537"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju044"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-1418"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu274"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.048"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.061"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-005-0879-3"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.10.046"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.12.1583"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23567"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.6489"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.3204"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.4.574"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa060185"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.3339"},{"key":"B59","doi-asserted-by":"crossref","unstructured":"Charif OE, Wheeler HE, Mushiroda T, et al: Genome-wide association study of cisplatin-induced peripheral neuropathy (CIPN) in testicular cancer survivors. J Clin Oncol 34, 2016 (suppl; abstr 4543)","DOI":"10.1200\/JCO.2016.34.15_suppl.4543"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2016.70.3108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T14:37:16Z","timestamp":1719067036000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2016.70.3108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,10]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,4,10]]}},"alternative-id":["10.1200\/JCO.2016.70.3108"],"URL":"https:\/\/doi.org\/10.1200\/jco.2016.70.3108","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,10]]},"assertion":[{"value":"2017-02-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}